LGR5 and malignant colon neoplasm: CASC15 has been observed to regulate the expression of leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5) by targeting miR-4310, thereby activating the Wnt/β-Catenin signaling pathway in colon cancer [44].